Shares up nearly 14% (Il Sole 24 Ore Radiocor) - Madrid, 08 Jul - Shares of Grifols, a Spanish provider of plasma-derived medicines and other biopharmaceutical solutions, were sharply higher on news that the company could be delisted.

At 1121 GMT, Grifols was 13.63% at 10.22 euros in Madrid.

The company said it had it received a joint takeover bid from its founding family and Canadian fund Brookfield. The parties aim to submit a definitive offer in the coming weeks following the request for further information on the company.

According to the daily Cinco Dias the deal could be worth around 5.5 billion euros.

AAA-Web

(RADIOCOR) 08-07-24 13:30:29 (0350) 5 NNNN